Paolo Caimi, Md

This early-phase trial is testing a new type of CAR-T cell therapy called LMY-920 for people with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) that has come back or stopped responding to other treatments. The therapy uses a protein called BAFF to help th…